Atlas Trials

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT00080340 · COMPLETED

Trial details

NCT number
NCT00080340
Sponsor
Telik
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non Small Cell Lung Carcinoma
Enrollment
520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.